Ping An Biomedical Co., Ltd.
Ping An Biomedical Co., Ltd., through its subsidiaries, provides supply chain management services in the apparel industry in China, Hong Kong, Cambodia, and Europe. The company offers market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. It also engages in the manufacturing and trading of yarns, textiles, and finish… Read more
Ping An Biomedical Co., Ltd. (PASW) - Total Liabilities
Latest total liabilities as of September 2025: $23.17 Million USD
Based on the latest financial reports, Ping An Biomedical Co., Ltd. (PASW) has total liabilities worth $23.17 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Ping An Biomedical Co., Ltd. - Total Liabilities Trend (2021–2025)
This chart illustrates how Ping An Biomedical Co., Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Ping An Biomedical Co., Ltd. Competitors by Total Liabilities
The table below lists competitors of Ping An Biomedical Co., Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Plato Gold Corp
OTCQB:NIOVF
|
USA | $3.18 Million |
|
Capital Partners S.A.
WAR:CPA
|
Poland | zł89.65K |
|
YeSUN Tech Co.Ltd.
KQ:250930
|
Korea | ₩37.75 Billion |
|
KEYENCE CORP
MU:KEE
|
Germany | €165.94 Billion |
|
Tashin Holdings Bhd
KLSE:0211
|
Malaysia | RM83.83 Million |
|
Cluey Ltd
AU:CLU
|
Australia | AU$6.73 Million |
|
Cofidur SA
PA:ALCOF
|
France | €48.16 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down Ping An Biomedical Co., Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.76 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.51 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.34 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ping An Biomedical Co., Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ping An Biomedical Co., Ltd. (2021–2025)
The table below shows the annual total liabilities of Ping An Biomedical Co., Ltd. from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | $23.17 Million | -63.81% |
| 2024-09-30 | $64.04 Million | -25.28% |
| 2023-09-30 | $85.70 Million | +10.80% |
| 2022-09-30 | $77.35 Million | +2.08% |
| 2021-09-30 | $75.77 Million | -- |